Clinical risk stratification of paediatric renal transplant recipients using C1q and C3d fixing of de novo donor-specific antibodies

scientific article published on 16 September 2017

Clinical risk stratification of paediatric renal transplant recipients using C1q and C3d fixing of de novo donor-specific antibodies is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00467-017-3772-7
P932PMC publication ID5700253
P698PubMed publication ID28918487

P50authorStephen D MarksQ88575714
Neil J. SebireQ38549176
George MichaelidesQ59393707
P2093author name stringRobert Vaughan
Nizam Mamode
Anthony Dorling
Chloe Martin
Olivia Shaw
Jon Jin Kim
Ramnath Balasubramaniam
P2860cites workThe perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejectionQ26862195
Long-term outcomes of children after solid organ transplantationQ28660815
Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.Q35027253
HLA sensitisation: can it be prevented?Q35097898
Capillary deposition of complement C4d and C3d in Chinese renal allograft biopsiesQ35189649
Cellular response to injury in membranous nephropathyQ36084457
Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients.Q36296061
IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated InjuryQ36417907
Calcineurin-inhibitor free immunosuppression with mycophenolate mofetil and corticosteroids in paediatric renal transplantation improves renal allograft function without increasing acute rejectionQ37320783
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.Q37667779
Complement as a multifaceted modulator of kidney transplant injuryQ38217273
Kidney transplantation in childrenQ38237543
Association of C1q-fixing DSA with late graft failure in pediatric renal transplant recipientsQ87395286
Determinants of C1q binding in the single antigen bead assayQ88058283
Complement activation in progressive renal diseaseQ38348940
Assessing Antibody Strength: Comparison of MFI, C1q, and Titer Information.Q40990548
Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the "creeping creatinine" studyQ45281312
Systematic comparison of four cell- and Luminex-based methods for assessment of complement-activating HLA antibodiesQ45332005
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantationQ45627897
Complement-binding anti-HLA antibodies and kidney-allograft survivalQ46141053
Early versus late acute antibody-mediated rejection in renal transplant recipients.Q46415040
Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition.Q53244973
The Clinical Spectrum ofDe NovoDonor-Specific Antibodies in Pediatric Renal Transplant RecipientsQ57521747
Acquisition of C3d-Binding Activity by De Novo Donor-Specific HLA Antibodies Correlates With Graft Loss in Nonsensitized Pediatric Kidney RecipientsQ87006000
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P304page(s)167-174
P577publication date2017-09-16
P1433published inPediatric NephrologyQ15749796
P1476titleClinical risk stratification of paediatric renal transplant recipients using C1q and C3d fixing of de novo donor-specific antibodies
P478volume33

Reverse relations

cites work (P2860)
Q89529172C3d-Positive Preformed DSAs Tend to Persist and Result in a Higher Risk of AMR after Kidney Transplants
Q59807564Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients
Q63866084Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure
Q92525914Prognostic value of C3d-fixing, preformed donor-specific antibodies in crossmatch-positive living kidney transplantation

Search more.